Protein-Profiling beim HELLP-Syndrom

Juliane Christine Finke

doi:10.18453/rosdok_id00000449

Juliane Christine Finke

Protein-Profiling beim HELLP-Syndrom

Universität Rostock, 2008

https://doi.org/10.18453/rosdok_id00000449

Abstract: There is no preclinical diagnosis for the HELLP-syndrome available. In this study we generated profiles of plasma proteins from HELLP-patients and healthy pregnants (2D gel electrophoresis, mass spectrometry). Statistically significant expressions were obtained in inter-alpha-trypsin inhibitor H4, kininogen 1, fibrinogen gamma, transthyretin, haptoglobins, and serum amyloid A (SAA). The differential expression of SAA was validated and quantitatively assayed by ELISA. SAA plasma levels were found to be above 3.51 mg/L in HELLP-syndrome and below 3.51 mg/L in the nonHELLP-group. The intention is to generate protein profiles that could function as marker signature for the HELLP syndrome.

doctoral thesis free access

title:

Protein-Profiling beim HELLP-Syndrom

contributing persons:

Juliane Christine Finke[VerfasserIn]
	137962444
Michael O. Glockner , Prof. Dr.[AkademischeR BetreuerIn]
Toralf Reimer , PD Dr. med.[AkademischeR BetreuerIn]
Marek Zygmunt , Prof. Dr. med.[AkademischeR BetreuerIn]

contributing corporate bodies:

Universität Rostock, Universitätsmedizin[Grad-verleihende Institution]
	1029510660

abstract:

Für das HELLP-Syndrom existiert keine präklinische Diagnostik. In dieser Arbeit wurden Plasmaprofile von HELLP-Patientinnen und gesunden Schwangeren erstellt und analysiert (2-D-Gelelektrophosese, Massenspektrometrie). Signifikante Unterschiede ergaben Inter-alpha-Trypsin-Inhibitor H4, Kininogen 1, Fibrinogen gamma, Transthyretin, Haptoglobin und Serum Amyloid A (SAA). Die Plasmakonzentration von SAA liegt in der HELLP-Gruppe über 3,51 mg/l und in der Kontrollgruppe unter 3,51 mg/l (ELISA). In unserem Patientenkollektiv ist eine Trennung zwischen HELLP und nonHELLP möglich. Ziel ist es, HELLP-spezifische Proteinprofile als Marker-Signaturen zu entwickeln. [German]

There is no preclinical diagnosis for the HELLP-syndrome available. In this study we generated profiles of plasma proteins from HELLP-patients and healthy pregnants (2D gel electrophoresis, mass spectrometry). Statistically significant expressions were obtained in inter-alpha-trypsin inhibitor H4, kininogen 1, fibrinogen gamma, transthyretin, haptoglobins, and serum amyloid A (SAA). The differential expression of SAA was validated and quantitatively assayed by ELISA. SAA plasma levels were found to be above 3.51 mg/L in HELLP-syndrome and below 3.51 mg/L in the nonHELLP-group. The intention is to generate protein profiles that could function as marker signature for the HELLP syndrome. [English]

document type:

doctoral thesis

institution:

University Medicine

language:

German

subject class (DDC):

610 Medical sciences Medicine

publication /
production:

Rostock: Universität Rostock

2008

identifiers: